Macrophages (M~) have the critical function of presenting antigens in a highly immunogenic form to responding antigen-specific T and B cells in the initiation of immune responses (1, 2) . In primary antibody responses to T-celldependent antigens in vitro, genetic restrictions in M~-lymphocyte interactions are not apparent (1) (2) (3) (4) . By contrast, interactions between ~ and immune T cells in the generation and functional expression of carrier-specific murine helper T cells in vitro (5) , DNA-synthetic responses to antigens by immune guinea pig (6, 7) and murine (8) T lymphocytes, and expression of delayed hypersensitivity reactions in mice (9) are controlled by products of the I region (or its equivalent) of the major histocompatibility complex (MHC) of the species. The environment in which these T cells are first exposed to antigens has emerged as a critical factor in the subsequent expression of the genetic restrictions (3, 4, 10) . Thus, immune murine lymphocytes develop secondary plaque-forming cell (PFC) responses preferentially when stimulated in vitro with antigen on M¢ syngeneic to the M~ used to immunize the spleen cells in vivo (3, 4) . These genetic restrictions are antigen-specific, they operate at the level of the immune T cell, and they are controlled by products of the I-A subregion of the H-2 complex (3, 4, 11) .
The products of MHC-linked immune response (Ir) genes themselves may be involved in mediating genetic restrictions in M¢-T-cell interactions. For example, in guinea pigs, immune (nonresponder × responder)F1 T cells develop DNA-synthetic responses to antigens under the control of MHC-linked Ir gene(s) when the antigen is associated with responder, but not nonresponder, parental lVkb (6, 7). These observations led to the hypothesis that the Ir gene product is functionally expressed in M~, and nonresponder M~ lack this product and are therefore unable to present antigens in an immunogenic form to stimulate the (3, 4, 14) , the defect in nonresponder mice does not appear to be expressed in the MS, but rather appears to be due to a preferential development of GAT-specific suppressor T cells (13, 15) . In light of the aforementioned studies with guinea pigs indicating M~b localized Ir gene defects, the capacity of responder and nonresponder MS to stimulate responses to GAT by spleen cells from virgin and immune (responder x nonresponder)F1 mice was investigated and is the subject of this communication. Antigens. GAT (Miles Laboratories Inc., Elkhart, Ind.), mol wt ~45,000, was prepared for use as antigen in culture (16), for preparing GAT-M¢ (3), and for coupling to sheep erythrocytes for use as indicator cells in the PFC assay (16) as previously described.
Materials and Methods
Culture System and Hemolytic Plaque Assay. At Harvard Medical School, spleen cells at 7.5
x 106 cells/ml in completely supplemented Eagle's minimal essential medium containing 10% fetal calf serum (Reheis Co., Inc., Kankakee, Ill.) and 10 mM N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid (Hepes) (Hepes-MEM) were incubated with GAT-M~b or GAT as 1-ml cultures in 16-mm wells of a 24-sample multiwell dish (FB-16-24TC; Linbro Chemical Co., New Haven, Conn.). At the Jewish Hospital, spleen cells at 107 cells/ml in completely supplemented MEM lacking Hepes were incubated and GAT-M(b or GAT as 1-ml cultures in 35-ram dishes (3001; Falcon Plastics, Div. of BioQuest, Oxnard, Calif.). After incubation for 5 days under Mishell-Dutton conditions, IgG GAT-specific PFC responses were assayed using the slide modification of the Jerne hemolytic plaque assay (16) .
Preparation of GAT-Mcb and Immunization of Mice.
The preparation of GAT-M¢ using peptone-induced peritoneal exudate has been described in detail previously (3) . F~ mice were immunized by i.p. injection of 4 x 10 ~ of the appropriate GAT-M~ (bearing ~ 25 ng GAT]106 cells) or 10 or 100 /zg GAT in a mixture of magnesium-aluminum hydroxide gel (Maalox; Win. H. Rorer, Inc., Ft. Washington, Pa.) and pertussis vaccine (Eli Lilly & Co., Indianapolis, Ind.) (16) .
Results
Responder x nonresponder (B6 x D1)F1 mice were immunized i.p. with 100 /~g GAT in Maalox-pertussis; 79 days later, spleen cells from these and virgin mice were assayed for development of IgG GAT-specific PFC responses to responder or nonresponder parental GAT-M~ and soluble GAT (Table I) (B6 × D1)F, spleen cells, by contrast, developed secondary PFC responses to responder (B6) GAT-IVI~ and soluble GAT, but not to nonresponder (D1) GAT-M~. Mixtures of equal numbers of B6 and D1 GAT-M6-stimulated responses comparable to those stimulated by the same number of B6 GAT-Mqb alone, except at the lowest numbers tested, where 5 x 103 B6 GAT-M~ also failed to stimulate a response. These data with mixtures of B6 and D1 M~b indicate that the failure of immune F, spleen cells to respond to the nonresponder D1 GAT-M& alone is not due to a nonspecific suppressive mechanism initiated by these
TABLE II

Secondary PFC Responses to GAT by Responder x Nonresponder (BIO x DI)F, Spleen Cells Stimulated by Parental GAT-M~b
M~.
In the next experiments, responder × nonresponder (B10 × D1)F, mice were immunized i.p. with 10 /~g GAT in Maalox-pertussis, or responder or nonresponder parental GAT-Mqb; 28 days later, spleen cells from these and virgin mice were assayed for development of IgG GAT-specific PFC responses to parental B10 and D1 GAT-M~b, third party C3H GAT-M~, and soluble GAT (Table II) . Virgin F~ spleen cells developed comparable primary responses to all GAT-MS and soluble GAT. The GAT-primed F1 spleen cells developed secondary responses to responder B10 GAT-MS and soluble GAT, but failed to respond to nonresponder D1 or third party C3H GAT-MS. Identical results were observed in responses of F1 spleen cells primed with responder B10 GAT-MS. By contrast, F, spleen cells primed with nonresponder D1 GAT-MS developed secondary responses with D1 GAT-MS and soluble GAT, but failed to respond to third party C3H or responder B10 GAT-MS. A preliminary study using responder x responder (B6 x D2)F~ mice immunized with GAT indicates that these spleen cells develop secondary PFC responses after stimulation with either B10 or D2 GAT-MS, but fail to respond to third party C3H GAT-MS.
Discussion
These experiments illustrate three major points concerning the ability of spleen cells from virgin and immune (responder x nonresponder)F1 mice to develop PFC responses after stimulation with GAT or parental GAT-M~b in vitro. First, virgin F1 spleen cells develop comparable primary IgG GATspecific PFC responses after stimulation with either parental or unrelated third party GAT-M~. Second, spleen cells from F1 mice immunized with either parental GAT-M~b develop secondary responses in vitro to the GAT-M~b used for immunization in vivo. These results are consistent with previous observations that spleen cells from mice immunized with syngeneic or allogeneic GAT-M~ develop secondary responses in vitro to GAT-M~b that are syngeneic at the I-A subregion of the H-2 complex with the M¢ used for priming (3, 4, 11) . In many of these experiments, M~b from nonresponder mice induced these genetic restrictions in spleen cells of homozygous responder mice (3, 4, 11) . These observations and others (14) , led to the earlier conclusion that the defect in nonresponder mice, in the case of GAT, was not in the M~b.
The third observation is that spleen cells from F1 mice immunized with GAT develop secondary responses in vitro only when stimulated with responder parental GAT-M¢. This indicates that in virgin (respender x nonrespender)F~ mice immunized with GAT, which would of necessity be presented by F1 M~b, the responder component of the F1 MS predominates and selectively primes a population of F1 T cells capable of being activated subsequently only by respender GAT-MS in culture. These results imply that Ir-gene function may be expressed in murine MS, and they are in agreement with observations in proliferative responses with F1 guinea pig lymphocytes (6, 7) and delayed hypersensitivity responses in F~ mice (12) .
We must now resolve the contradiction between; (a) the ability of nonresponder GAT-M~ to stimulate primary responses in both homozygous responder and heterozygous (responder x nonresponder)F1 mice, and to prime these mice such that secondary responses are restricted to the nonresponder GAT-M~b, and (b) the failure of GAT-primed F1 mice to develop secondary responses to nonresponder GAT-M~b. It is possible that Ir-gene function is expressed in murine M~ and that nonresponder M~b express some, but not all, of these functions with regard to GAT. Thus, only in certain circumstances (e.g. the F~ animal), would these differences be revealed. The expression of only one set of responder Ir gene(s) in the immunocompetent cells of the heterozygous, (re-spender × nonresponder)F, may impose restrictions on the interactions among F, M~b and different subsets of T cells during priming with GAT. Alternatively, if, as demonstrated in guinea pigs (17) , F, mice possess distinct subsets of T cells, each capable of interacting with one but not the other parental Me, it is possible that helper T cells specific for responder GAT-M~ are primed by injection of GAT, whereas helper T cells capable of responding to nonresponder GAT-M~b are not primed. This hypothesis is supported by these previous observations in nonresponder mice: (a) GAT induces suppressor, but not radioresistant helper T cells (13, 14, 18) ; (b) radioresistant GAT-specific helper T cells can be induced by injection of nonresponder mice with GAT-M~ or GAT-MBSA (13, 18) ; and, (c) injection of GAT not only induces suppressor T cells, but also prevents the development of GAT-specific helper T cells after injection of GAT-MBSA (13).
Summary
The development of IgG L-glutamic acid6°-L-alanine3°-L-tyrosine '° (GAT)-specific plaque-forming cell responses in vitro by virgin and immune (responder x nonresponder)F, spleen cells after stimulation with responder and nonresponder parental GAT-macrophages (M~b) was investigated. Virgin F, spleen cells developed comparable primary responses to both parental GAT-M&. By contrast, F, spleen cells from mice immunized with GAT or responder parental GAT-M& developed secondary responses after stimulation with only responder parental GAT-M~. Spleen cells from F~ mice immunized with nonresponder parental GAT-M~b developed secondary responses to these GAT-M~b, but failed to respond to respender parental GAT-M~. These results are discussed in the context of genetic restrictions regulating M~b-T-cell interactions in secondary antibody responses and the possible expression of Ir-gene function in M~b.
